900 related articles for article (PubMed ID: 25998428)
1. [The application of CRISPR-Cas9 gene editing technology in viral infection diseases].
Yin LJ; Hu SQ; Guo F
Yi Chuan; 2015 May; 37(5):412-8. PubMed ID: 25998428
[TBL] [Abstract][Full Text] [Related]
2. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
Pellagatti A; Dolatshad H; Valletta S; Boultwood J
Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
[TBL] [Abstract][Full Text] [Related]
3. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
4. [The application of CRISPR/Cas9 genome editing technology in cancer research].
Wang DY; Ma N; Hui Y; Gao X
Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518
[TBL] [Abstract][Full Text] [Related]
5. Targeted Mutagenesis of Guinea Pig Cytomegalovirus Using CRISPR/Cas9-Mediated Gene Editing.
Bierle CJ; Anderholm KM; Wang JB; McVoy MA; Schleiss MR
J Virol; 2016 Aug; 90(15):6989-6998. PubMed ID: 27226370
[TBL] [Abstract][Full Text] [Related]
6. Genome editing using Cas9 nickases.
Trevino AE; Zhang F
Methods Enzymol; 2014; 546():161-74. PubMed ID: 25398340
[TBL] [Abstract][Full Text] [Related]
7. Advances in therapeutic CRISPR/Cas9 genome editing.
Savić N; Schwank G
Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
[TBL] [Abstract][Full Text] [Related]
8. [Application progress of CRISPR/Cas9 genome editing technology in the treatment of HIV-1 infection].
Han Y; Li QW
Yi Chuan; 2016 Jan; 38(1):9-16. PubMed ID: 26787519
[TBL] [Abstract][Full Text] [Related]
9. The application of genome editing in studying hearing loss.
Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 for genome editing: progress, implications and challenges.
Zhang F; Wen Y; Guo X
Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
[TBL] [Abstract][Full Text] [Related]
11. Application of CRISPR-Cas9 in eye disease.
Wu W; Tang L; D'Amore PA; Lei H
Exp Eye Res; 2017 Aug; 161():116-123. PubMed ID: 28619505
[TBL] [Abstract][Full Text] [Related]
12. RNA-guided genome editing in plants using a CRISPR-Cas system.
Xie K; Yang Y
Mol Plant; 2013 Nov; 6(6):1975-83. PubMed ID: 23956122
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9 gene editing: A new therapeutic approach in the treatment of infection and autoimmunity.
Mohammadzadeh I; Qujeq D; Yousefi T; Ferns GA; Maniati M; Vaghari-Tabari M
IUBMB Life; 2020 Aug; 72(8):1603-1621. PubMed ID: 32344465
[TBL] [Abstract][Full Text] [Related]
14. Mutagenesis and Genome Engineering of Epstein-Barr Virus in Cultured Human Cells by CRISPR/Cas9.
Yuen KS; Chan CP; Kok KH; Jin DY
Methods Mol Biol; 2017; 1498():23-31. PubMed ID: 27709566
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
Zhang WW; Matlashewski G
mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
[TBL] [Abstract][Full Text] [Related]
16. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
Grenier F; Lucier JF; Rodrigue S
Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
[TBL] [Abstract][Full Text] [Related]
17. CRISPR Mediated Genome Engineering and its Application in Industry.
Kaboli S; Babazada H
Curr Issues Mol Biol; 2018; 26():81-92. PubMed ID: 28879858
[TBL] [Abstract][Full Text] [Related]
18. [Application of CRISPR-Cas9 genome editing for constructing animal models of human diseases].
Ou Z; Sun X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Aug; 33(4):559-63. PubMed ID: 27455021
[TBL] [Abstract][Full Text] [Related]
19. Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment.
Kennedy EM; Cullen BR
Virology; 2015 May; 479-480():213-20. PubMed ID: 25759096
[TBL] [Abstract][Full Text] [Related]
20. A short overview of CRISPR-Cas technology and its application in viral disease control.
Ghorbani A; Hadifar S; Salari R; Izadpanah K; Burmistrz M; Afsharifar A; Eskandari MH; Niazi A; Denes CE; Neely GG
Transgenic Res; 2021 Jun; 30(3):221-238. PubMed ID: 33830423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]